A physician-designed investigational protocol utilizing 100% medical-grade oxygen in hard-shell hyperbaric chambers. This study is intended to promote research into neurological and systemic cellular responses associated with high-pressure oxygen therapy.
Request Screening CallParticipation is voluntary. Enrollment subject to physician clearance and study eligibility criteria.
Sessions
Intensive cadence designed to assist with long-term angiogenesis research.
Medical O₂
Pure oxygen saturation delivered in hard-shell chambers at therapeutic pressures (1.5–2.4 ATA).
Supervised
Direct physician oversight and mandatory pre-study diagnostic clearance.
The following criteria are intended to assist with preliminary self-qualification. Final eligibility determination is made by the study physician.
Final eligibility is determined by the study physician during screening.
This investigational study is designed to assist with research in the following areas:
Researching the impact of high-pressure oxygen on neuro-inflammation and executive function markers.
Assessing biological markers of inflammation and oxidative stress over a 60-session period.
Evaluating healing acceleration associated with complex soft-tissue or post-surgical recovery needs.
Investigating cellular senescence and mitochondrial health through structured hyper-oxygenation protocols.
This investigational study advertisement and protocol are subject to IRB/Ethics Committee review.
Your inquiry has been received. A member of our clinical team will contact you within 2-3 business days to schedule a preliminary screening call.
During the screening call, we will discuss study eligibility, protocol details, and answer any questions you may have about this investigational study.